An ancillary genomics system to support the return of pharmacogenomic results

Existing approaches to managing genetic and genomic test results from external laboratories typically include filing of text reports within the electronic health record, making them unavailable in many cases for clinical decision support. Even when structured computable results are available, the lack of adopted standards requires considerations for processing the results into actionable knowledge, in addition to storage and management of the data. Here, we describe the design and implementation of an ancillary genomics system used to receive and process heterogeneous results from external laboratories, which returns a descriptive phenotype to the electronic health record in support of pharmacogenetic clinical decision support.

[1]  Ching-Hon Pui,et al.  PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[2]  Abel N. Kho,et al.  Practical challenges in integrating genomic data into the electronic health record , 2013, Genetics in Medicine.

[3]  Elaine Lyon,et al.  The GeneInsight suite: a platform to support laboratory and provider use of DNA‐based genetic testing , 2011, Human mutation.

[4]  Oscar Pastor,et al.  Genetic Testing Information Standardization in HL7 CDA and ISO13606 , 2013, MedInfo.

[5]  Suzette J. Bielinski,et al.  Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems , 2014, Clinical pharmacology and therapeutics.

[6]  Christopher G Chute,et al.  Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. , 2014, Mayo Clinic proceedings.

[7]  Justin Starren,et al.  Crossing the omic chasm: a time for omic ancillary systems. , 2013, JAMA.

[8]  Lisa P. Newmark,et al.  A novel clinician interface to improve clinician access to up-to-date genetic results. , 2014, Journal of the American Medical Informatics Association : JAMIA.

[9]  Diane Hauser,et al.  The IGNITE network: a model for genomic medicine implementation and research , 2015, BMC Medical Genomics.

[10]  M R Wilkinson,et al.  A Clinician‐Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record , 2012, Clinical pharmacology and therapeutics.

[11]  Marcin Imielinski,et al.  The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations , 2016, J. Am. Medical Informatics Assoc..

[12]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[13]  T. Klein,et al.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network , 2011, Clinical pharmacology and therapeutics.

[14]  Nikhil Wagle,et al.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. , 2016, American journal of human genetics.

[15]  Heidi L. Rehm,et al.  Communicating new knowledge on previously reported genetic variants , 2012, Genetics in Medicine.

[16]  David W. Bates,et al.  Usability of a novel clinician interface for genetic results , 2012, J. Biomed. Informatics.

[17]  M. A. Hoffman,et al.  The genome-enabled electronic medical record , 2007, J. Biomed. Informatics.

[18]  Isaac S. Kohane,et al.  Technical desiderata for the integration of genomic data into Electronic Health Records , 2012, J. Biomed. Informatics.

[19]  PJ Caraballo,et al.  Electronic Medical Record‐Integrated Pharmacogenomics and Related Clinical Decision Support Concepts , 2017, Clinical pharmacology and therapeutics.

[20]  Aniwaa Owusu Obeng,et al.  Clinical pharmacogenetics implementation: Approaches, successes, and challenges , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[21]  J. Cherry,et al.  Providing Access to Genomic Variant Knowledge in a Healthcare Setting: A Vision for the ClinGen Electronic Health Records Workgroup , 2016, Clinical pharmacology and therapeutics.

[22]  Peter Tarczy-Hornoch,et al.  Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing , 2015, Genetics in Medicine.

[23]  Lisa P. Newmark,et al.  Evaluation: A Qualitative Pilot Study of Novel Information Technology Infrastructure to Communicate Genetic Variant Updates , 2016, Applied Clinical Informatics.

[24]  Jeffrey C. Hall,et al.  The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–Pharmacogenomics , 2013, Clinical pharmacology and therapeutics.

[25]  Hallvard Lærum,et al.  A taste of individualized medicine: physicians' reactions to automated genetic interpretations. , 2014, Journal of the American Medical Informatics Association : JAMIA.

[26]  Timur Beyan,et al.  Incorporation of Personal Single Nucleotide Polymorphism (SNP) Data into a National Level Electronic Health Record for Disease Risk Assessment, Part 2: The Incorporation of SNP into the National Health Information System of Turkey , 2014, JMIR medical informatics.